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Abstract
Objective—To determine, for the WHO algorithm for point-of-care diagnosis of HIV infection,
the agreement levels between pediatricians and non-physician clinicians, and to compare
sensitivity and specificity profiles of the WHO algorithm and different CD4 thresholds against
HIV PCR testing in hospitalized Malawian infants.
Methods—In 2011, hospitalized HIV-exposed infants <12 months in Lilongwe, Malawi were
evaluated independently with the WHO algorithm by both a pediatrician and clinical officer.
Blood was collected for CD4 and molecular HIV testing (DNA or RNA PCR). Using molecular
testing as the reference, sensitivity, specificity, and positive predictive value (PPV) were
determined for the WHO algorithm and CD4 count thresholds of 1500 and 2000 cells/mm3 by
pediatricians and clinical officers.
Results—We enrolled 166 infants (50% female, 34% <2 months, 37% HIV-infected). Sensitivity
was higher using CD4 thresholds (<1500, 80%; <2000, 95%) than with the algorithm (physicians,
57%; clinical officers, 71%). Specificity was comparable for CD4 thresholds (<1500, 68%, <2000,
50%) and the algorithm (pediatricians, 55%, clinical officers, 50%). The positive predictive values
were slightly better using CD4 thresholds (<1500, 59%, <2000, 52%) than the algorithm
(pediatricians, 43%, clinical officers 45%) at this prevalence.
Conclusion—Performance by the WHO algorithm and CD4 thresholds resulted in many
misclassifications. Point-of-care CD4 thresholds of <1500 cells/mm3 or <2000 cells/mm3 could
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identify more HIV-infected infants with fewer false positives than the algorithm. However, a
point-of-care option with better performance characteristics is needed for accurate, timely HIV
diagnosis.
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Introduction
Despite great strides in prevention of mother-to-child transmission (PMTCT) of HIV
infection in developing countries, approximately 330,000 children acquire HIV each year,
more than 90% of these in sub-Saharan Africa1. More than half of these HIV-infected
children will die within two years without antiretroviral therapy (ART).2,3 Early ART
initiation within the first few months of life is even more beneficial, reducing infant
mortality by 76% and HIV progression by 75%.4
Although early ART initiation hinges on timely infant diagnosis, diagnosing HIV in this age
group poses major challenges. First, point-of-care antibody tests cannot definitively
diagnose HIV since maternal antibodies circulate in some infants until 18 months of age.5
Second, HIV PCR testing using DNA or RNA is definitive but results are frequently delayed
due to slow turnaround times at specialized central referral laboratories and loss to follow-
up.6 Ultimately, up to 70% of HIV-infected children may not receive HIV PCR results.7 As
a consequence, HIV-related mortality continues among undiagnosed infants in HIV-endemic
African countries.
Two potential alternatives to infant HIV PCR testing are the WHO clinical algorithm for
symptomatic HIV infection and point-of-care CD4 testing.8 The WHO clinical algorithm
enables clinicians to immediately initiate potentially life-saving ART for infants meeting its
criteria,9 circumventing the long delays plaguing current PCR testing systems. Malawi, a
southern African country with epidemic HIV, recommended use of this algorithm during
routine care, with subsequent HIV DNA PCR confirmation starting in 2008.10 To date little
is known about the sensitivity and specificity profiles of this algorithm when used by non-
physician clinicians, as previous work focused on algorithm performance solely by
pediatricians with sensitivities of 23–77% and specificities between 53–93%.11–14 This
knowledge gap is critical since non-physician clinicians, not pediatricians, deliver the
majority of clinical care in Malawi and other high HIV prevalence African countries.
Point-of-care CD4 cell count testing also offers a potential diagnostic alternative to HIV
PCR. CD4 count testing can be made available at the point of care with existing technology.
Performance characteristics at different CD4 count thresholds have not been explored.
Furthermore, direct comparisons between the performance of different CD4 count
thresholds, CD4 percentages, the WHO algorithm, and gold standard PCR testing have not
been thoroughly studied. If point-of-care CD4 testing were to outperform the WHO clinical
algorithm, it would provide an immediate laboratory-based point-of-care option for infant
HIV diagnosis and ART eligibility.
Maliwichi et al. Page 2






















Our primary objectives for this study were 1) to determine WHO algorithm agreement levels
between pediatricians and non-physician clinicians, and 2) to compare sensitivity and
specificity profiles of the WHO algorithm and different CD4 thresholds against HIV PCR
testing in hospitalized Malawian infants. We hypothesized that pediatricians would
outperform non-physician clinicians in using the WHO algorithm and that a CD4 threshold
which outperforms clinical diagnosis could be identified.
Methods
Study Setting
This study was performed among hospitalized children in the pediatric wards of Kamuzu
Central Hospital (KCH) in Lilongwe, Malawi. With pediatrics, KCH serves as both a
referral and district hospital, has 215 beds, admits more than 13,000 children annually, and
has an inpatient pediatric HIV prevalence of 8.5%.15 Since 2008, hospitalized children and
their caregivers have been routinely offered HIV antibody testing as part of an inpatient
pediatric HIV testing program in accordance with Malawi guidelines. 15 Children are
subsequently eligible for DNA PCR if HIV antibody-positive and younger than 12 months.
A WHO algorithm evaluation by either a pediatrician or clinical officer (CO) also occurs,
but less routinely, since assessment depends upon the practitioner’s training and preference.
Study Procedures
This sub-study took place between February and November 2011 and was nested within a
prospective randomized controlled trial. 16 The parent study’s primary objective was to
compare outcomes of standard of care that included a pediatrician examination with the
WHO algorithm plus laboratory-based HIV DNA PCR (turnaround time of several weeks)
with a rapidly processed HIV RNA PCR test (turnaround time of 48 hours). Study subjects
of the parent study were hospitalized at KCH, were consented by a guardian, were less than
12 months of age, and were HIV-exposed without a definitive HIV status. At enrollment
blood was collected from all participants for PCR HIV testing (either DNA or RNA PCR per
randomization outcome), CD4 absolute cell count and percentages, complete blood count
and differential, malaria smear, and blood culture. Chest radiographs and tuberculin skin
tests were also done, with induced sputum tests performed only for patients with clinical
suspicion of Mycobacterium tuberculosis or Pneumocystis jirovecii infection.
Study infants testing HIV antibody-positive using the standard Malawi HIV testing
algorithm were eligible for this sub-study. The algorithm consisted of serial testing with
Determine HIV-1/2 (Alere) first, followed by Unigold Recombigen HIV-1/2 (Trinity
Biotech) for those testing antibody positive. Both a study pediatrician and one non-physician
CO evaluated each sub-study infant, also at the time of enrollment into the parent study,
filled out an algorithm checklist for each criterion, and assigned either a positive or negative
HIV status per WHO algorithm criteria. For an infant to be considered algorithm-positive
they needed either two HIV-related conditions (oral thrush, severe or very severe
pneumonia, or severe sepsis) or one AIDS-specific condition (P.jirovecii pneumonia,
esophageal candidiasis, treatment-unresponsive severe acute malnutrition, extra-pulmonary
tuberculosis disease, Kaposi sarcoma, cerebral toxoplasmosis with onset after one month of
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age, or cryptococcal meningitis). The pediatrician and COs were blinded to one another’s
clinical evaluations and to PCR results. However, they were not blinded to the PMTCT and
breast-feeding history of the mother-infant pair.
All COs working in the KCH pediatric wards were invited to participate in the sub-study,
provided written informed consent, underwent a half-day training in the WHO algorithm and
study procedures, and completed a questionnaire and written competency test. COs were the
practitioners of interest since they are the primary cadre of non-physician clinicians in
Malawi and provide the majority of Malawian pediatric hospital care.
We retrospectively assessed CD4 performance at multiple percentage and absolute CD4
count thresholds. Infants with values below the CD4 threshold were classified “positive” and
those with values above the threshold were classified as “negative.” We assessed CD4
percentages because they are preferred for HIV management in infants, and absolute counts
because point-of-care technology is available currently, though not used in this assessment.
Analytic Methods
Normally distributed continuous covariates were described using means and standard
deviations and categorical characteristics were presented as proportions. Level of agreement
in assignment of overall WHO algorithm status and individual algorithm conditions were
compared between COs and the pediatrician using proportion of overall agreement and
Cohen’s kappa statistic.
The reference standard used for HIV infection was a positive HIV DNA PCR or RNA PCR
with >10,000 copies/ml. The performance of the pediatrician, COs, and CD4 thresholds
(both absolute count and percentages) were compared to this standard. We also compared
each individual WHO algorithm condition to this standard. Sensitivity and specificity were
calculated, along with 95% confidence intervals (CI). Given these sensitivities and
specificities, the positive predictive value (PPV), negative predictive value (NPV) and
corresponding 95% CIs were calculated at HIV prevalence levels from 0% to 100%,
including the prevalence in this population. Additionally, we calculated the total number of
errors expected (false positives plus false negatives) in a population of 1000 infants at each
CD4 count threshold. We varied two sets of assumptions. First we varied the relative weight
of a false negative and false positive result (i.e. that a false positive and a false negative
result were equal or that a false negative result would be three times worse than a false
positive result). We also varied the prevalence of HIV infection in the population from 5%
(the projected prevalence under improved PMTCT policies) and 37% (the prevalence in this
sub-study).
All pediatric data were analyzed using SAS 9.3 (SAS Institute, Cary NC). CO characteristics
were analyzed in Microsoft Excel. Completeness and accuracy in conduct and reporting of
this study was assessed using the STARD initiative checklist. 17
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We received ethical approval from the Malawi National Health Sciences Research
Committee and the Institutional Review Boards at The University of North Carolina at
Chapel Hill and Baylor College of Medicine.
Results
Of all hospitalized infants <12 months 13.1% (323/2465) were HIV-exposed (Figure 1).
Research staff enrolled 300 infants into the parent study, of whom 237 (79%) tested HIV
antibody-positive and were eligible for this sub-study. Both the study pediatrician and one
CO examined 70.0% (166/237) of these HIV antibody-positive infants. COs were not
available to examine all 237 eligible infants due to logistical conflicts.
Table 1 presents patient characteristics. Exactly half (83/166) of study subjects were female
with a median age of 3.3 months (interquartile range=1.5–7.4 months) irrespective of
gender. The majority of infants (84%) were breast feeding, of whom 64% (89/139) were
breastfeeding exclusively. Most infants received at least partial PMTCT as 66% of mothers
reported antenatal ART prophylaxis and 59% reported that their infant received ART
prophylaxis after birth.
Participating COs were generally young (mean age 25.4 years, range 21–32 years) and
without substantial clinical or pediatric HIV experience (mean 2.3 years clinical experience;
mean 1.6 years pediatric HIV experience [Table 2]). Prior to this study only two of seven
COs were both nationally certified in HIV and also trained in pediatric HIV. COs and
pediatricians arrived at the same diagnosis on 67% (112/166) of the infants. An overall
“fair” agreement level18 in the assignment of WHO clinical algorithm status was achieved
between COs and the study pediatrician (mean kappa 0.35, 95% CI: 0.21, 0.49), ranging
from 0.18 to 0.59. We also assessed overall agreement levels for the diagnosis of specific
WHO clinical algorithm conditions between participating COs and the study pediatrician
using the kappa statistic, where 0 is no agreement, 1 is complete agreement (data not
shown), and negative values reflect less agreement than would be expected at random.
Except for almost no agreement found for the diagnosis of severe malnutrition
(kappa=0.03), kappa agreement levels ranged from 0.28 for sepsis to 0.62 for oral Candida.
We next examined the sensitivity of the WHO algorithm when applied by clinicians and
CD4 thresholds as compared to gold standard DNA or RNA molecular testing (Table 3).
Overall, 61/166 infants (37%) were HIV-infected. The sensitivity of the WHO algorithm
was lower when used by pediatricians (57%) versus COs (71%). However, 5/43 cases
classified as algorithm-positive by COs did not actually meet criteria according to their own
evaluation. For example, some checked “HIV-positive” even if the infant only had one HIV-
related condition. If COs had correctly interpreted the WHO algorithm for all patients, the
sensitivity of the algorithm would have decreased to 62%. For both pediatricians and COs,
the most sensitive clinical condition was severe or very severe pneumonia (71% for
pediatricians and 57% for COs). Sensitivity increased with both CD4 percentages (28%
sensitive at CD4 <15% to 85% sensitive at CD4<30%) and CD4 count (25% sensitive at
CD4 <500 cells/mm3 to 95% sensitive at CD4 <2000 cells/mm3).
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In addition to studying the sensitivity of the WHO algorithm and CD4 thresholds, we also
studied specificity. In all, 105/166 infants (63%) were HIV-uninfected. Pediatricians
achieved a higher specificity (55%) with use of the WHO algorithm as compared to COs
(50%). When algorithm performance was corrected for 16 patients misclassified by COs as
algorithm-positive, despite their own evaluation indicating otherwise, the specificity of the
algorithm increased from 50% to 65%. Compared to HIV PCR testing, the specificity
decreased with higher CD4 percentage and absolute count thresholds. Specifically,
specificity was 99% at a CD4 percentage <15%, and 73% at CD4<30%. Specificity was
98% at an absolute CD4 count <500 cells/mm3 and 50% at a CD4 <2000 cells/mm3.
At the 37% prevalence, the PPV for CD4 percentage thresholds ranged from 94% at CD4
<15%, to 65% at CD4 <30% (Figure 2C). For absolute CD4 count testing, the PPV ranged
from 88% at CD4 <500 cells/mm3 to 52% at CD4 <2000 cells/mm3 (Figure 2B). NPV
ranged from 72% at CD4 <15%, to 90% at CD4 <30% and 69% at CD4 count <500
cells/mm3 to 95% at CD4 <2000 cells/mm3.
Several trends emerged when assessing PPV and NPV using the WHO algorithm, and all
CD4 thresholds over a spectrum of prevalence levels (Figure 2). First, at any prevalence,
both PPV and NPV of CD4 <1000, CD4 <1500, and CD4 <2000 were better than PPV and
NPV among either of the clinician cadres. At the study prevalence (37%) PPV was best
(88%) at CD4 <500, and at this value CD4 NPV was almost identical to that of both
clinician cadres. CD4 <2000 was the worst CD4 count threshold for PPV (52%), but still
better than use of the WHO algorithm by either type of clinician.
Because CD4 count thresholds outperformed the WHO algorithm and could become
available at the point of care, we explored which thresholds would minimize the number of
errors (Table 3). At 37% prevalence, when false negatives and false positives were weighted
equally, the total number of errors increased monotonically from 29 per 100 infants screened
at a CD4 threshold of <500 cells/mm3 to 34 per 100 infants screened at a threshold of <2000
cells/mm3. When a false negative was weighted three times more heavily, the opposite trend
emerged: the total number of errors decreased monotonically from 85 per 100 infants
screened at <500 cells/mm3 to 37 per 100 infants screened at <2000 cells/mm3. At a 10%
prevalence when false negatives and false positives were weighted equally, the total number
of errors increased monotonically from 9 per 100 infants screened at <500 cells/mm3 to 46
per 100 infants screened <2000 cells/mm3. But when a false negative was weighted three
times more heavily, the relationship between CD4 count threshold and number of errors per
100 infants screened was not monotonic: 24 errors at CD4 <500 cells/mm3, 23 errors at CD4
<1000 cells/mm3, 35 errors at CD4 <1500 cells/mm3, and 47 errors at <2000
cells/mm3(Table 4). The choice of the optimal CD4 count threshold is quite sensitive to both
the relative weight of false negative and false positive result and the prevalence.
Discussion
Unacceptably high rates of mother-to-child HIV transmission and pediatric mortality
continue in part because a reliable point-of-care HIV diagnostic test for infants is not yet
routinely available in resource-constrained African countries with epidemic HIV. This study
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examined two types of existing point-of-care diagnostic approaches that could be utilized for
infant HIV diagnosis until an acceptable molecular test is available, the WHO clinical
algorithm for symptomatic HIV infection in infants and the CD4 test. Overall we found the
accuracy of infant HIV diagnosis using the WHO clinical algorithm or CD4 to be inferior to
gold standard molecular HIV testing (DNA or RNA PCR) in hospitalized Malawian infants.
Both COs and pediatricians missed a large share of HIV-infected infants using the WHO
algorithm. Higher CD4 count thresholds (>1500 cells/mm3 or >25%), though also sub-
optimal, performed markedly better at identifying HIV-infected infants in our patient
population.
This study addressed an important knowledge gap regarding the use of the WHO algorithm
by COs, a cadre of non-physician clinicians that provide the majority of pediatric HIV care
in Malawi and are common throughout sub-Saharan Africa.19 The performance of the WHO
algorithm by the pediatrician in this study was comparable to that observed in WHO
algorithm validation studies done in Kenya12 and Zambia14 (low sensitivity) and Rwanda11
(low specificity). Our study found that there was only fair agreement with algorithm use
between COs and pediatricians (Kappa = 0.35) on an individual patient basis. However, COs
and pediatricians had similar performance overall with respect to the sensitivity and
specificity of the algorithm when compared to molecular HIV testing. COs displayed a trend
towards better sensitivity and pediatricians displayed a trend towards better specificity,
though these differences were not statistically significant at an alpha level of 0.05. In
summary, using the WHO algorithm COs were able to assess infant HIV status as well as
pediatricians in this setting.
Although the two cadres performed similarly to each other, the WHO algorithm is poorly
sensitive and specific for detecting infant HIV in this setting. Using the WHO algorithm at
least 30% of HIV-infected infants were not identified by either clinician cadre and the
majority of those identified as HIV-infected by both cadres were actually HIV-uninfected.
Similar performance of the WHO algorithm was also observed in other studies assessing this
algorithm.11–14
Since point-of-care molecular testing is not yet available, this study explored the
performance of different CD4 thresholds in an effort to identify an existing alternative to the
WHO algorithm. CD4 count testing could be made available at the point of care. In some
settings CD4 count is comparable to CD4 percentages, the preferred metric in infants.20–22
We have shown that using CD4 count thresholds can improve sensitivity over clinical
diagnosis without compromising PPV at any given prevalence. Previous studies have
assessed the performance of the CD4 <25% threshold in similar infant populations and
found sensitivities between 55%11 and 72%12 and specificities from 39%12 to 88%13. Other
studies have assessed clinical criteria performance in combination with CD4<25% and
demonstrated improved algorithm performance11–14. Choosing an optimal CD4 count
threshold is challenging and requires careful consideration. Initiating HIV-uninfected infants
on ART is the compromise of using a less specific HIV diagnostic test and should be done
with caution. Falsely identifying infants as HIV-infected may result in medication side
effects, misdirected use of scarce health care resources, and psychosocial strain on the
family. To avoid these potential issues, a highly specific diagnostic is desirable. On the other
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hand, maximizing sensitivity is likely to minimize mortality because more HIV-infected
infants can be initiated on ART in a timely fashion. Thus we consider weighing a false
negative more heavily than a false positive to be reasonable. A CD4 count of 2000
cells/mm3 identified nearly all the HIV-infected infants (95%). At 37% prevalence,
assuming a false negative is three times worse than a false positive, a CD4 count threshold
of 2000 cells/mm3 optimizes the potential diagnostic algorithm.
But the optimal CD4 threshold will vary depending on the prevalence of HIV among infants,
and should therefore be individually tailored to each setting’s HIV prevalence prior to
implementation and reviewed over time as HIV prevalence changes. For example, in
Malawi HIV prevalence is likely to decline over time due to Option B+, a PMTCT program
started in 2011 that provides free lifetime ART to all HIV-infected pregnant and
breastfeeding women.23 In our setting, if prevalence among hospitalized infants declines to
10%, the optimal CD4 count threshold would be <1000 cells/mm3. Since our study relied on
data preceding Option B+ implementation, additional modeling or a pilot study assessing
different CD4 thresholds at the point-of-care for HIV-exposed Malawian infants in this new
context could be informative.
There are several reasons why the WHO algorithm may have underperformed compared to
molecular testing. First, the individual conditions used in the algorithm themselves may not
be good predictors of HIV in this population. For example, sepsis and pneumonia are
prevalent among both HIV-infected and HIV-uninfected infants in this population (Table 3),
and thus poorly specific for predicting HIV. Second, individual algorithm conditions may
have been inaccurately classified, thereby limiting accuracy of clinicians who adhere to the
algorithm. Third, COs misclassified some infants by not adhering to the algorithm. Previous
evidence has reported poor adherence to clinical criteria for both pneumonia diagnosis and
oxygen eligibility by Malawian COs.19 In this study we similarly report inconsistent CO
adherence to the WHO algorithm for infant HIV diagnosis.
The results observed in this hospital-based study may not be generalizable to outpatient
Malawian clinics due to several factors. Hospitalized infants are generally sicker than HIV
exposed-infants presenting to outpatient care and HIV prevalence is also higher in the
hospital compared to the community. Therefore, fewer infants presenting for routine
outpatient care are likely to meet algorithm criteria for an HIV-positive diagnosis. Only one
pediatrician and seven COs participated in this single facility study. A larger multicenter
study in diverse settings with more practitioners is needed to confirm our findings.
In conclusion, accurate, timely HIV infant diagnosis is critical for access to life-saving ART
but is not occurring in the current Malawian infant HIV diagnosis system that relies on
slowly processed DNA PCR tests. Ideally, an infant HIV point-of-care diagnostic that is
highly sensitive, specific, and affordable is desired. Until such a test is available, we
recommend implementing point-of-care CD4 testing as an infant diagnostic, with thresholds
based on local HIV prevalence levels.
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Figure 1. Study Population
Figure 1 displays the proportion of infants included and excluded from the parent trial and
this sub-analysis. The proportions of infants who were HIV-infected and HIV-uninfected
were determined with HIV RNA or HIV DNA PCR.
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Figure 2A. Positive and Negative Predictive Values of the WHO Algorithm as a Function of
HIV Prevalence
Figure 2B. Positive and Negative Predictive Values of CD4 Count Thresholds as a Function
of HIV Prevalence
Figure 2C. Positive and Negative Predictive Values of CD4 Percentage Thresholds as a
Function of HIV Prevalence
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 Male 83 (50%)
 Female 83 (50%)
Age
 <2 months 57 (34%)
 2–6 months 58 (35%)
 >6 months 51 (31%)
Maternal PMTCT
 Yes 107 (66%)
 No 56 (33%)
Infant PMTCT
 Yes 98 (59%)
 No 68 (41%)
Mother alive
 Yes 161 (98%)
 No 4 (2%)
Breastfeeding status
 Exclusive 89 (54%)
 Mixed 50 (30%)
 No 27 (16%)
PMTCT indicates prevention of mother-to-child transmission.
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